DARE

Dare Bioscience News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Dare Bioscience Inc DARE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0197 1.99% 1.01 0.9801 1.01 1.01 0.9903 18:45:53
more quote information »

Recent News

Date Time Source Heading
6/26/202016:23EDGARCurrent Report Filing (8-k)
6/24/202008:00GLOBEDaré Bioscience Announces Publication of a Peer-Reviewed..
6/17/202008:00GLOBEDaré Bioscience Announces Initiation of Pivotal Phase 3..
6/15/202008:00GLOBEDaré Bioscience Announces Receipt of $1.5 Million Under the..
6/09/202006:00EDGARNotice of Effectiveness (effect)
6/08/202016:27EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/08/202006:02EDGARCurrent Report Filing (8-k)
6/04/202008:00GLOBEDaré Bioscience Announces Participation in BIO Digital 2020
6/03/202016:08EDGARCurrent Report Filing (8-k)
5/20/202006:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/15/202016:15EDGARSecurities Registration Statement (simplified Form) (s-3)
5/14/202016:06EDGARQuarterly Report (10-q)
5/14/202008:00GLOBEDaré Bioscience Reports First Quarter 2020 Financial Results..
5/13/202006:01EDGARNotice of Effectiveness (effect)
5/12/202016:21EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/11/202008:00GLOBEDaré Bioscience and Health Decisions Form Strategic..
5/07/202008:00GLOBEDaré Bioscience to Host First Quarter 2020 Financial Results..
5/01/202016:05EDGARSecurities Registration Statement (s-1)
5/01/202006:47EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/28/202008:00GLOBEDaré Bioscience CEO to Participate in Maxim Group’s..
4/27/202006:13EDGARCurrent Report Filing (8-k)
4/23/202016:04EDGARCurrent Report Filing (8-k)
4/23/202008:00GLOBEDaré Bioscience Announces Common Stock Purchase Agreement..
4/22/202016:18EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/22/202016:05EDGARProxy Statement (definitive) (def 14a)
4/14/202012:02EDGARSec Staff Action/letter (sec Staff)
4/14/202012:02EDGARSec Staff Action/letter (sec Staff)
4/01/202017:03EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/01/202008:00GLOBEDaré Bioscience Receives Third Notice of Award from National..
3/30/202016:09EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/30/202008:00GLOBEDaré Bioscience Reports 2019 Financial Results and Provides..
3/27/202016:26EDGARAnnual Report (10-k)
3/24/202008:00GLOBEDaré Bioscience to Host Fourth Quarter and Full-year 2019..
3/16/202016:12EDGARCurrent Report Filing (8-k)
3/10/202008:00GLOBEDaré Bioscience Receives FDA Fast Track Designation for..
3/09/202017:48EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202017:44EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202017:43EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202017:26EDGARInitial Statement of Beneficial Ownership (3)
3/09/202008:00GLOBEDaré Bioscience Presents Positive Sildenafil Cream, 3.6%..
2/27/202008:00GLOBEDaré Bioscience to Present at the Cowen 40th Annual Health..
2/21/202016:41EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
2/21/202016:19EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/12/202016:49EDGARStatement of Ownership (sc 13g)
2/12/202016:05GLOBEAnika Therapeutics Names Board Member Dr. Cheryl Blanchard..
2/10/202016:04EDGARCurrent Report Filing (8-k)
2/06/202008:53EDGARCurrent Report Filing (8-k)
2/06/202008:00GLOBEDaré Bioscience Regains Compliance with Nasdaq Minimum..
2/05/202008:00GLOBEDaré Bioscience to Present at the 2020 BIO CEO & Investor..
2/05/202006:04EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
NASDAQ
DARE
Dare Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200707 00:16:08